Skip to content

Suicide Prevention for Patients With Chronic Pain

Suicide Prevention for Patients With Chronic Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04490265
Enrollment
60
Registered
2020-07-29
Start date
2020-05-20
Completion date
2023-12-27
Last updated
2025-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Suicide

Brief summary

Patients with chronic pain and moderate suicide risk (n=60) will be randomized to receive remote-PST or remote-supportive psychotherapy. We will assess problem-solving deficits through self-report, objective neuropsychological assessment and caregiver report. We have used an adaptive design so that if there is strong evidence for target engagement, we will continue with the trial as a fully powered clinical trial (i.e., the end of the current proposal will act as the interim assessment) to the determine the efficacy of remote PST for patients with chronic pain and moderate suicide risk (n=190) to improve suicide outcomes.

Detailed description

Every day, 120 people die from suicide, that is one person every 15 minutes.1 Suicide prevention treatments focus on those at highest risk and are primarily delivered as mental health treatments,2-5 and yet 70% of patients with suicide risk do not attend mental health treatment. Developing treatment for patients not served by existing suicide prevention programs will improve access to care and is necessary to stop suicide. Patients with chronic pain in the US (100 million) have 2.6-times greater risk of suicide and those on long-term opioid treatment are at even greater risk. Unfortunately, they often do not receive mental health treatment and thus do not receive suicide prevention interventions. They do receive frequent healthcare for their pain providing an unmet opportunity to integrate suicide prevention into their treatment for pain. Problem-solving treatment (PST) is an evidence-based approach that is available where patients want to receive treatment (e.g., primary care) and is efficacious for chronic pain. Importantly, PST targets problem-solving deficits which are known to increase risk of suicide, suggesting PST could be leveraged to reduce suicide risk. Deficits in problem-solving (an executive function of finding solutions to difficult issues) directly increase suicidal risk because they keep patients with active suicidal ideation from generating solutions to their problems (e.g., chronic pain), other than through suicide. Deficits in problem-solving also make it difficult to keep pain from impairing daily activities and social relationships. This indirectly increases suicide risk because impairment in daily activities increases feelings of burdensomeness and impairment in social relationships increases feelings of not belonging. Feelings of burdensomeness and of not belonging are key theoretical pathways to suicidal behavior. Working with our clinical partners and patients, we developed a 12-week remote delivered PST for patients with chronic pain and moderate suicidal risk. The treatment addresses deficits in problem-solving by teaching patients strategies to address problems caused by chronic pain that increase risk of suicide (e.g., impairment in daily activities leading to feelings of burdensomeness). Our preliminary data suggests that PST is feasible, acceptable and may be efficacious. In a national survey we found 56% of patients with chronic pain and suicide risk were interested in problem-solving treatment. In a clinical pilot we were able to engage Veterans with chronic pain and suicide risk with 75% completing the treatment. Finally, in a clinical trial that randomized patients to 12 sessions of PST or 12 sessions of health education, we found that patients with chronic pain and moderate suicide risk (n=21) randomized to PST had a reduction in suicidal ideation and problem-solving deficits (self-report) as compared to health education. The goal of the current proposal (R56) is to ensure PST is engaging problem-solving deficits. Patients with chronic pain and moderate suicide risk (n=60) will be randomized to receive remote-PST or remote-supportive psychotherapy. We will assess problem-solving deficits through self-report, objective neuropsychological assessment and caregiver report. We have used an adaptive design so that if there is strong evidence for target engagement, we will continue with the trial as a fully powered clinical trial (i.e., the end of the current proposal will act as the interim assessment) to the determine the efficacy of remote PST for patients with chronic pain and moderate suicide risk (n=190) to improve suicide outcomes. Aim 1: Estimate the effect of remote-delivered PST on targets. We hypothesize that PST reduces our primary target, problem-solving deficits as assessed through (H1) self-report, (H2) objective neuropsychological assessment, (H3) caregiver report, as compared to supportive psychotherapy. We hypothesize that PST reduces our secondary targets (H1) feelings of burdensomeness and (H2) feelings of not belonging, as compared to supportive psychotherapy. Exploratory Aim 2: Explore the effect size of PST as compared to supportive psychotherapy on suicide outcomes (intensity of suicidal ideation, difficulties coping with suicidal ideation) and chronic pain outcomes ((H4) chronic pain, (H5) pain related disability). Our previous preliminary data suggests that PST is feasible, acceptable and may be efficacious. The goal of the current proposal (R56) is to confirm PST is engaging problem-solving deficits (measured through self-report and objective measures). Deliverable: At the end of the proposed trial, we will have the necessary information (in combination with our previous preliminary data) to inform a go/no-go decision on converting the current proposal into a fully powered clinical trial.

Interventions

included in arm descriptions

BEHAVIORALSupportive Psychotherapy

included in arm descriptions

Sponsors

Rutgers University
CollaboratorOTHER
Veterans BioMedical Research Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

will include: * has a VA primary care provider and has had an in-person visit with a VA provider in the past year; * pain that is (b1) musculoskeletal, defined as regional (joints, limbs, back, neck) or more generalized (chronic widespread pain); * pain that is (b2) moderately severe, defined as a Brief Pain Inventory (BPI) intensity item score of 5 or higher for either average or worst pain in the past week; * pain that is (b3) persistent, (i.e., ≥3 months) * active suicidal ideation defined as scoring a 2 to 4 on the C-SSRS.

Exclusion criteria

* life-threatening condition * severe cognitive impairment * psychotic disorder * pregnant or plans to become pregnant in the next year * suicide attempt in the past year or hospitalization for suicide risk in the past year

Design outcomes

Primary

MeasureTime frameDescription
Social Problem-solving Inventory - Patient ReportChange from Baseline to 12 weeksThe Social problem-solving inventory - patient report measures problem-solving that is sensitive to change. In clinical research, the Social problem-solving inventory - patient report has been successfully used to elicit meaningful self-appraisals. The questionnaire is 52 items long. We will use the total score. Scores range from 0-100 with higher scores equaling better problem-solving.
Emotional StroopChange from Baseline to 12 weeksThe emotional Stroop is a test of response inhibition. There are four category conditions: aggression, color, negative, and positive. Scores were derived based on the difference between the median latency of neutral condition subtracted from median latency of category conditions (unit=miliseconds) with higher scores equaling better problem-solving. Score range did not exceed -500 to 500.
Iowa Gambling TaskChange from Baseline to 12-weeksThe Iowa gambling task is a neuropsychological task of problem-solving. The participgoal of the task is to make money. Participants are presented four decks of cards and have to choose the best deck to make money. The Iowa gambling task has been shown to change after problem-solving therapy. Scores range from -100 to 100 with higher equaling better problem-solving.
Means End Problem-Solving TaskChange from Baseline to 12 weeksThe Means End Problem-Solving Task consists of a series of scenarios, with each one identifying the beginning and end of a story. The subject's task is to come up with the middle of the story. Stories are scored according to how many steps to reaching the end the patient identifies. An increase in effective means generated is expected to drive reduction in suicide ideation. We report the total score, the range was 2-19. Scores higher=better problem-solving.
Emotional Go No GoChange from Baseline to 12 weeksEmotional Go No Go measures attention and impulse inhibition. Inhibiting impulses is a key component of preventing impulsive behavior that can lead to suicide. Reported is the hit rate with scores from 0-1.0. Higher scores are better.

Secondary

MeasureTime frameDescription
Interpersonal Needs QuestionnaireChange from Baseline to 12 weeks, Baseline to 6 monthsFeelings of burdensomeness and belongingness will be measured by the Interpersonal Needs Questionnaire (INQ). This measure is 18-item self-report questionnaire. The belonging subscale is 6 items and scores range from 6-42 with higher scores indicating less belonging, the burdensomeness subscale is 9 items and scores range from 9-63 with higher scores indicating greater burdensomeness.

Other

MeasureTime frameDescription
Columbia-Suicide Severity Rating Scale (C-SSRS)Change from Baseline to 12 weeks and Baseline to 6 monthsColumbia-Suicide Severity Rating Scale (C-SSRS) is the gold standard for suicide assessment and measures level and intensity of suicidal ideation, planning and preparation for suicidal behavior, and method and lethality of recent (past week) and past lifetime suicidal behavior. The intensity of ideation subscale (the summed score from five separate items on Part II; subscale range = 2-25) will be the primary dependent variable for the fully powered clinical trial. The intensity of ideation asks about the intensity of ideation in the past 6 months (e.g., the frequency, duration controllability). Higher scores are equal to greater ideation.
Brief Pain Inventory (BPI)Change from Baseline to 12 weeksBrief Pain Inventory (BPI) measure of pain severity and interference. The total severity composite score ranges from 0-10 with higher scores indicating worse pain. The total pain interference score ranges from 0-10 with higher scores indicating more interference.
Pain Disability Index (PDI)Change from Baseline to 12 weeksPain Disability Index (PDI) is a 7 item measure of the impact of pain on daily activities and social relationships. It will be used to assess disability from pain. The PDI ranges from 0-70 with higher scores indicating worse disability from pain.
Suicide-Related Coping ScaleChange from Baseline to 12 weeksThe Suicide-Related Coping Scale captures an individual's perceived ability to use internal and external coping to problem-solve suicidal thoughts and urges. This measure was validated in a Veteran sample. The items in this measure capture the types of skills we expect Veterans to be able to use after learning problem-solving (i.e., I recognize the circumstances that make me suicidal). Scores range from 0-68 with higher scores indicating better coping.
Suicide Ideation Questionnaire (SIQ).Change from Baseline to 12 weeksSuicide Ideation Questionnaire (SIQ) is a 30-item self-report instrument designed to assess thoughts about suicide experienced during the prior month. This measure has strong internal consistency and construct validity. This measure will allow for supplementary investigation of ideation. Scores range from 7-210 with higher equaling worse ideation.

Countries

United States

Participant flow

Pre-assignment details

Enrolled = Participants who enrolled into the study (n=60) Baseline = Participants who consented into the study and were randomized (n=44)

Participants by arm

ArmCount
Problem-Solving Treatment
Our PST is 12-weeks and teaches patients strategies to address real-life problems.20 Sessions are once a week for one hour except for the first session, which is two hours. The treatment has four main goals: 1. Safety planning; 2. Problem-orientation-addressing how patients approach problems; 3. Planful problem-solving or a logical approach to address problems; 4. Behavioral activation of daily activities. Patients are provided weekly worksheets on problem-solving and receive weekly assessment of emotional state and suicidal ideation monitoring. Problem-solving treatment: included in arm descriptions
20
Supportive Psychotherapy
Our control will be supportive psychotherapy which will focus on discussing weekly stressors in a supportive, non-directive way. Session content is patient-driven, and sessions focus on emphasizing the patients' strengths, following patients' emotional affect, and building a therapeutic alliance. Participants will be asked to generate the topic they would like to discuss for the session and will complete a worksheet between sessions noting emotional events throughout their week (A time when I felt stressed was … ) in order to help identify experiences for discussion in session. Participants will be informed that the control condition is supportive and non-directive, and that providers will not engage in problem-solving. Providers will be taught to use reflective listening, clarification, empathy, and validation. The control consists of 12 weekly sessions delivered via telephone or video. Supportive Psychotherapy: included in arm descriptions
21
Total41

Baseline characteristics

CharacteristicProblem-Solving TreatmentTotalSupportive Psychotherapy
Age, Continuous48.2 years50.4 years52.5 years
Ethnicity (NIH/OMB)
Hispanic or Latino
4 Participants5 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
15 Participants35 Participants20 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants1 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
2 Participants3 Participants1 Participants
Race (NIH/OMB)
Black or African American
3 Participants7 Participants4 Participants
Race (NIH/OMB)
More than one race
1 Participants1 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
4 Participants4 Participants0 Participants
Race (NIH/OMB)
White
10 Participants26 Participants16 Participants
Sex: Female, Male
Female
4 Participants8 Participants4 Participants
Sex: Female, Male
Male
16 Participants33 Participants17 Participants
Social Problem-Solving82.16 units on a scale
STANDARD_DEVIATION 18.2
85.65 units on a scale
STANDARD_DEVIATION 20.37
88.81 units on a scale
STANDARD_DEVIATION 22.33

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 220 / 22
other
Total, other adverse events
21 / 2215 / 22
serious
Total, serious adverse events
4 / 222 / 22

Outcome results

Primary

Emotional Go No Go

Emotional Go No Go measures attention and impulse inhibition. Inhibiting impulses is a key component of preventing impulsive behavior that can lead to suicide. Reported is the hit rate with scores from 0-1.0. Higher scores are better.

Time frame: Change from Baseline to 12 weeks

Population: Only individuals who provided data were analyzed.

ArmMeasureValue (MEAN)
Problem-Solving TreatmentEmotional Go No Go-.01 score on a scale
Supportive PsychotherapyEmotional Go No Go.06 score on a scale
Primary

Emotional Stroop

The emotional Stroop is a test of response inhibition. There are four category conditions: aggression, color, negative, and positive. Scores were derived based on the difference between the median latency of neutral condition subtracted from median latency of category conditions (unit=miliseconds) with higher scores equaling better problem-solving. Score range did not exceed -500 to 500.

Time frame: Change from Baseline to 12 weeks

Population: Only individuals who provided data were analyzed.

ArmMeasureGroupValue (MEAN)
Problem-Solving TreatmentEmotional StroopColor123.00 score on a scale
Problem-Solving TreatmentEmotional StroopAggression59.21 score on a scale
Problem-Solving TreatmentEmotional StroopNegative55.50 score on a scale
Problem-Solving TreatmentEmotional StroopPositive97.67 score on a scale
Supportive PsychotherapyEmotional StroopPositive71.14 score on a scale
Supportive PsychotherapyEmotional StroopAggression13.50 score on a scale
Supportive PsychotherapyEmotional StroopColor59.49 score on a scale
Supportive PsychotherapyEmotional StroopNegative72.71 score on a scale
Primary

Iowa Gambling Task

The Iowa gambling task is a neuropsychological task of problem-solving. The participgoal of the task is to make money. Participants are presented four decks of cards and have to choose the best deck to make money. The Iowa gambling task has been shown to change after problem-solving therapy. Scores range from -100 to 100 with higher equaling better problem-solving.

Time frame: Change from Baseline to 12-weeks

Population: Only individuals who provided data were analyzed.

ArmMeasureValue (MEAN)
Problem-Solving TreatmentIowa Gambling Task23.33 score on a scale
Supportive PsychotherapyIowa Gambling Task26.14 score on a scale
Primary

Means End Problem-Solving Task

The Means End Problem-Solving Task consists of a series of scenarios, with each one identifying the beginning and end of a story. The subject's task is to come up with the middle of the story. Stories are scored according to how many steps to reaching the end the patient identifies. An increase in effective means generated is expected to drive reduction in suicide ideation. We report the total score, the range was 2-19. Scores higher=better problem-solving.

Time frame: Change from Baseline to 12 weeks

Population: Only individuals who provided data were analyzed.

ArmMeasureValue (MEAN)
Problem-Solving TreatmentMeans End Problem-Solving Task-1.36 score on a scale
Supportive PsychotherapyMeans End Problem-Solving Task0.29 score on a scale
Primary

Social Problem-solving Inventory - Patient Report

The Social problem-solving inventory - patient report measures problem-solving that is sensitive to change. In clinical research, the Social problem-solving inventory - patient report has been successfully used to elicit meaningful self-appraisals. The questionnaire is 52 items long. We will use the total score. Scores range from 0-100 with higher scores equaling better problem-solving.

Time frame: Change from Baseline to 12 weeks

Population: Only individuals who provided data were analyzed.

ArmMeasureValue (MEAN)
Problem-Solving TreatmentSocial Problem-solving Inventory - Patient Report8.12 score on a scale
Supportive PsychotherapySocial Problem-solving Inventory - Patient Report3.64 score on a scale
Primary

Social Problem-solving Inventory - Patient Report

The Social problem-solving inventory - patient report measures problem-solving that is sensitive to change. In clinical research, the Social problem-solving inventory - patient report has been successfully used to elicit meaningful self-appraisals. The questionnaire is 52 items long. We will use the total score.Scores range from 0-100 with higher scores equaling better problem-solving.

Time frame: Change from Baseline to 6 months

Population: Only individuals who provided data were analyzed.

ArmMeasureValue (MEAN)
Problem-Solving TreatmentSocial Problem-solving Inventory - Patient Report8.31 score on a scale
Supportive PsychotherapySocial Problem-solving Inventory - Patient Report-.24 score on a scale
Secondary

Interpersonal Needs Questionnaire

Feelings of burdensomeness and belongingness will be measured by the Interpersonal Needs Questionnaire (INQ). This measure is 18-item self-report questionnaire. The belonging subscale is 6 items and scores range from 6-42 with higher scores indicating less belonging, the burdensomeness subscale is 9 items and scores range from 9-63 with higher scores indicating greater burdensomeness.

Time frame: Change from Baseline to 12 weeks, Baseline to 6 months

Population: Only individuals who provided data were analyzed.

ArmMeasureGroupValue (MEAN)
Problem-Solving TreatmentInterpersonal Needs QuestionnaireBelonging - follow-up-2.37 score on a scale
Problem-Solving TreatmentInterpersonal Needs QuestionnaireBurden-follow-up-4.37 score on a scale
Problem-Solving TreatmentInterpersonal Needs QuestionnaireBelonging-6 months-.4 score on a scale
Problem-Solving TreatmentInterpersonal Needs QuestionnaireBurden - 6 months-3.2 score on a scale
Supportive PsychotherapyInterpersonal Needs QuestionnaireBurden - 6 months.11 score on a scale
Supportive PsychotherapyInterpersonal Needs QuestionnaireBelonging - follow-up-.81 score on a scale
Supportive PsychotherapyInterpersonal Needs QuestionnaireBelonging-6 months-.79 score on a scale
Supportive PsychotherapyInterpersonal Needs QuestionnaireBurden-follow-up-.5 score on a scale
Comparison: Belonging Subscale change from baseline to 12-weeks
Comparison: Belonging subscale Baseline to 6-months
Comparison: Change in Burdensome subscale Baseline to 12-weeks
Comparison: Change in Burdensome subscale Baseline to 6 months
Other Pre-specified

Brief Pain Inventory (BPI)

Brief Pain Inventory (BPI) measure of pain severity and interference. The total severity composite score ranges from 0-10 with higher scores indicating worse pain. The total pain interference score ranges from 0-10 with higher scores indicating more interference.

Time frame: Change from Baseline to 6 months

Population: Only individuals who provided data were analyzed.

ArmMeasureGroupValue (MEAN)
Problem-Solving TreatmentBrief Pain Inventory (BPI)Composite Score.82 score on a scale
Problem-Solving TreatmentBrief Pain Inventory (BPI)Interference.58 score on a scale
Supportive PsychotherapyBrief Pain Inventory (BPI)Interference-.29 score on a scale
Supportive PsychotherapyBrief Pain Inventory (BPI)Composite Score-.18 score on a scale
Comparison: Severity Subscale
Comparison: Interference subscale
Other Pre-specified

Brief Pain Inventory (BPI)

Brief Pain Inventory (BPI) measure of pain severity and interference. The total severity composite score ranges from 0-10 with higher scores indicating worse pain. The total pain interference score ranges from 0-10 with higher scores indicating more interference.

Time frame: Change from Baseline to 12 weeks

Population: Only individuals who provided data were analyzed.

ArmMeasureGroupValue (MEAN)
Problem-Solving TreatmentBrief Pain Inventory (BPI)Composition.33 score on a scale
Problem-Solving TreatmentBrief Pain Inventory (BPI)Interference-.2 score on a scale
Supportive PsychotherapyBrief Pain Inventory (BPI)Composition-.13 score on a scale
Supportive PsychotherapyBrief Pain Inventory (BPI)Interference.77 score on a scale
Comparison: Severity
Comparison: interference
Other Pre-specified

Columbia-Suicide Severity Rating Scale (C-SSRS)

Columbia-Suicide Severity Rating Scale (C-SSRS) is the gold standard for suicide assessment and measures level and intensity of suicidal ideation, planning and preparation for suicidal behavior, and method and lethality of recent (past week) and past lifetime suicidal behavior. The intensity of ideation subscale (the summed score from five separate items on Part II; subscale range = 2-25) will be the primary dependent variable for the fully powered clinical trial. The intensity of ideation asks about the intensity of ideation in the past 6 months (e.g., the frequency, duration controllability). Higher scores are equal to greater ideation.

Time frame: Change from Baseline to 12 weeks and Baseline to 6 months

Population: Only individuals who provided data were analyzed.

ArmMeasureGroupValue (MEAN)
Problem-Solving TreatmentColumbia-Suicide Severity Rating Scale (C-SSRS)follow-up-.82 score on a scale
Problem-Solving TreatmentColumbia-Suicide Severity Rating Scale (C-SSRS)6-months-1.23 score on a scale
Supportive PsychotherapyColumbia-Suicide Severity Rating Scale (C-SSRS)follow-up-1.14 score on a scale
Supportive PsychotherapyColumbia-Suicide Severity Rating Scale (C-SSRS)6-months-.5 score on a scale
Comparison: Baseline to 12-weeks
Comparison: Baseline to 6-months
Other Pre-specified

Pain Disability Index (PDI)

Pain Disability Index (PDI) is a 7 item measure of the impact of pain on daily activities and social relationships. It will be used to assess disability from pain. The PDI ranges from 0-70 with higher scores indicating worse disability from pain.

Time frame: Change from Baseline to 12 weeks

Population: Only individuals who provided data were analyzed.

ArmMeasureValue (MEAN)
Problem-Solving TreatmentPain Disability Index (PDI)-4.88 score on a scale
Supportive PsychotherapyPain Disability Index (PDI)2.13 score on a scale
Other Pre-specified

Pain Disability Index (PDI)

Pain Disability Index (PDI) is a 7 item measure of the impact of pain on daily activities and social relationships. It will be used to assess disability from pain.The PDI ranges from 0-70 with higher scores indicating worse disability from pain.

Time frame: Change from Baseline to 6 months

Population: Only individuals who provided data were analyzed.

ArmMeasureValue (MEAN)
Problem-Solving TreatmentPain Disability Index (PDI)-2.79 score on a scale
Supportive PsychotherapyPain Disability Index (PDI)1.06 score on a scale
Other Pre-specified

Suicide Ideation Questionnaire (SIQ).

Suicide Ideation Questionnaire (SIQ) is a 30-item self-report instrument designed to assess thoughts about suicide experienced during the prior month. This measure has strong internal consistency and construct validity. This measure will allow for supplementary investigation of ideation. Scores range from 7-210 with higher equaling worse ideation.

Time frame: Change from Baseline to 6 months

Population: Only individuals who provided data were analyzed.

ArmMeasureValue (MEAN)
Problem-Solving TreatmentSuicide Ideation Questionnaire (SIQ).-21.71 score on a scale
Supportive PsychotherapySuicide Ideation Questionnaire (SIQ).-7.0 score on a scale
Other Pre-specified

Suicide Ideation Questionnaire (SIQ).

Suicide Ideation Questionnaire (SIQ) is a 30-item self-report instrument designed to assess thoughts about suicide experienced during the prior month. This measure has strong internal consistency and construct validity. This measure will allow for supplementary investigation of ideation. Scores range from 7-210 with higher equaling worse ideation.

Time frame: Change from Baseline to 12 weeks

Population: Only individuals who provided data were analyzed.

ArmMeasureValue (MEAN)
Problem-Solving TreatmentSuicide Ideation Questionnaire (SIQ).-19.28 score on a scale
Supportive PsychotherapySuicide Ideation Questionnaire (SIQ).-2.88 score on a scale
Other Pre-specified

Suicide-Related Coping Scale

The Suicide-Related Coping Scale captures an individual's perceived ability to use internal and external coping to problem-solve suicidal thoughts and urges. This measure was validated in a Veteran sample. The items in this measure capture the types of skills we expect Veterans to be able to use after learning problem-solving (i.e., I recognize the circumstances that make me suicidal). Scores range from 0-68 with higher scores indicating better coping.

Time frame: Change from Baseline to 12 weeks

Population: Only individuals who provided data were analyzed.

ArmMeasureValue (MEAN)
Problem-Solving TreatmentSuicide-Related Coping Scale1.94 score on a scale
Supportive PsychotherapySuicide-Related Coping Scale4.06 score on a scale
Other Pre-specified

Suicide-Related Coping Scale

The Suicide-Related Coping Scale captures an individual's perceived ability to use internal and external coping to problem-solve suicidal thoughts and urges. This measure was validated in a Veteran sample. The items in this measure capture the types of skills we expect Veterans to be able to use after learning problem-solving (i.e., I recognize the circumstances that make me suicidal). Scores range from 0-68 with higher scores indicating better coping.

Time frame: Change from Baseline to 6 months

Population: Only individuals who provided data were analyzed.

ArmMeasureValue (MEAN)
Problem-Solving TreatmentSuicide-Related Coping Scale1.53 score on a scale
Supportive PsychotherapySuicide-Related Coping Scale3.33 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026